CIA
GILD icon

Concurrent Investment Advisors’s Gilead Sciences GILD Stock Holding History

Concurrent Investment Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-100
Closed -$8.38K – 1163
2024
Q3 		$8.38K Hold
100
– – ﹤0.01% 1076
2024
Q2 		$6.86K Hold
100
– – ﹤0.01% 979
2024
Q1 		$7.33K Buy
+100
New +$7.69K ﹤0.01% 912

Other funds holding GILD

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
Asset Management One
Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return

Concurrent Investment Advisors's GILD Position: Q2 2026 in Review

Concurrent Investment Advisors increased its Gilead Sciences (GILD) stake by 8.6% in Q2 2026, buying an estimated $854K and bringing the position to 81,664 shares worth $10.3M. The position accounts for 0.09% of the portfolio, ranked #250.

Concurrent Investment Advisors first reported a position in GILD in Q4 2023 and has held it in 11 quarters since. The position peaked at $10.5M in Q1 2026. 769 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Concurrent Investment Advisors held 81,664 shares of Gilead Sciences worth $10.3M as of Q2 2026.
  • Concurrent Investment Advisors bought 6,479 Gilead Sciences shares in Q2 2026, an estimated $854K.
  • Gilead Sciences made up 0.09% of Concurrent Investment Advisors's portfolio in Q2 2026, its #250 holding.
  • Concurrent Investment Advisors first reported a position in Gilead Sciences in Q4 2023 and has held it in 11 quarters since.
  • Concurrent Investment Advisors's Gilead Sciences position peaked at $10.5M in Q1 2026.
  • 769 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Concurrent Investment Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.